Acasti Pharma Announces Dariush Mozaffarian, M.D., Dr.P.H. Principal Investigator for CaPre Phase 3 Development Program Nov 7, 2017
Acasti Pharma Announces Issuance of Common Shares in Payment of Outstanding Interest under Debentures Oct 4, 2017
Acasti Pharma Announces the Election of Its Directors, Changes to Its Stock Option Plan and Other Related Matters Approved at Its AGM Aug 16, 2017
Acasti Pharma Announces Issuance of Common Shares in Payment of Outstanding Interest Under Debentures Jul 28, 2017
